Electronic cigarette effectiveness and abuse liability: Predicting and regulating nicotine flux

Nicotine and Tobacco Research

Volumn 17, Issue 2, 2015, Pages 158-162

  Shihadeh, Alan ^a,b   Eissenberg, Thomas ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE;

AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CLINICAL EFFECTIVENESS; CONCEPTUAL FRAMEWORK; DECISION MAKING; ELECTRONICS; HUMAN; NAUSEA AND VOMITING; NOTE; PRIORITY JOURNAL; REINFORCEMENT; SMOKING; SMOKING CESSATION; SMOKING HABIT; TOBACCO; TOBACCO DEPENDENCE; TOBACCO USE; ADVERSE EFFECTS; BEHAVIOR; DEVICES; ELECTRONIC CIGARETTE; EQUIPMENT DESIGN; LEGISLATION AND JURISPRUDENCE; PSYCHOLOGY;

BEHAVIOR; ELECTRONIC CIGARETTES; EQUIPMENT DESIGN; HUMANS; NICOTINE; SMOKING;

EID: 84922436123     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu175     Document Type: Note

References (21)

1. Breland AB, Spindle TR, Weaver M, Eissenberg T. Science and electronic cigarettes: current data, future needs. J Addict Med. 2014;8: 223-233.
2. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2012;15: 158-166.
3. Talih S, Balhas Z, Eissenberg T, et al. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions [published online ahead of print September 03, 2014]. Nicotine Tob Res.
4. Westenberger BJ. Evaluation of E-cigarettes. Rockville, MD: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis; 2009. www.fda.gov/downloads/drugs/scienceresearch/ucm173250.pdf. Accessed May 15, 2014.
5. Balster RL, Schuster CR. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration1. J Exp Anal Behav. 1973;20: 119-129.
6. Carter LP, Stitzer ML, Henningfield JE, O'Connor RJ, Cummings KM, Hatsukami DK. Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev. 2009;18: 3241-3262.
7. USDHHS. The Health Consequences of Smoking-50 Years of Progress: Nicotine Addiction: A Report of the Surgeon General. Rockville, MD: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, US Department of Health and Human Services; 2014.
8. Connolly GN, Alpert HR, Wayne GF, Koh H. Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997-2005. Tob Control. 2007;16:e5.
9. Land T, Keithly L, Kane K, et al. Recent increases in efficiency in cigarette nicotine delivery: implications for tobacco control. Nicotine Tob Res. 2014;16: 753-758.
10. Coultas DB, Stidley CA, Samet JM. Cigarette yields of tar and nicotine and markers of exposure to tobacco smoke. Am Rev Respir Dis. 1993;148: 435-440.
11. Djordjevic MV, Stellman SD, Zang E. Doses of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst. 2000;92: 106-111.
12. Kleykamp BA, Jennings JM, Sams C, Weaver MF, Eissenberg T. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp Clin Psychopharmacol. 2008;16: 99-112.
13. Eissenberg T. Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models. Addiction. 2004;99: 5-29.
14. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19: 1945-1953.
15. Hajek P. Electronic cigarettes for smoking cessation. Lancet. 2013;382: 1614-1616.
16. Wagener TL, Siegel M, Borrelli B. Electronic cigarettes: achieving a balanced perspective. Addiction. 2012;107: 1545-1548.
17. Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? J Am Med Assoc. 2014;311: 135-136.
18. Donny EC, Hatsukami DK, Benowitz NL, Sved AF, Tidey JW, Cassidy RN. Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation [published online ahead of print June 23, 2014]. Prev Med.
19. Shihadeh AL, Eissenberg TE. Significance of smoking machine toxicant yields to blood-level exposure in water pipe tobacco smokers. Cancer Epidemiol Biomarkers Prev. 2011;20: 2457-2460.
20. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010;19: 98-103.
21. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19: 1945-1953.